Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

by Foley JE, Bhosekar V, Kawamori R
Published 2016-01-01

DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes

by Kozlovski P, Bhosekar V, Foley JE
Published 2017-03-01